Items tagged with Treatment
Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis: 2011 update (document)
The recommendations in these guidelines address the topical questions concerning the programmatic management of drug-resistant TB: case-finding, multidrug resistance, treatment regimens, monitoring the response to treatment, and selecting models of care. They encourage the wider use of rapid drug-susceptibility testing with molecular techniques to detect rifampicin resistance in TB patients and provide appropriate treatment. Ambulatory models of care to manage patients with drug-resistant TB are recommended over others based mainly on hospitalization.
The Global Plan to Stop TB (document)
The Global Plan to Stop TB 2011-2015 retains the full spirit of its predecessor, Global Plan to Stop TB 2006-2015, while providing a clearer blueprint for action, setting out what needs to be done to achieve the 2015 targets set within the context of the MDGs and by the Stop TB Partnership. It takes in to account significant policy changes and costs to antiretroviral therapy, updates to the MDR-TB component of the plan, updates to estimates of epidemiological burden and trends, the importance of giving a higher profile to laboratory strengthening and the necessity to address the full spectrum of research.
Latent Tuberculosis Infection: A Guide for Primary Health Care Providers (document)
This guide is intended for primary care providers who care for patients who may be at risk for latent TB infection (LTBI) to progress to TB disease. Recommendations include: Treatment Regimens, Special Considerations in the Treatment of LTBI, Adverse Effects of Drugs Used to Treat LTBI, Patient Monitoring and Education During Treatment, Assessing Adherence, Techniques to Improve Adherence, and Post-Treatment Follow-Up. Most recent recommendations also include the use of interferon-gamma release assays (IGRAs).
Policy Guidelines for Collaborative TB and HIV Services for Injecting and Other Drug Users: An Integrated Approach (document)
These policy guidelines provide a strategic approach and new recommendations for integrated TB and HIV services for patients suffering from substance-abuse addiction. The key recommendations fall under three main categories: joint planning, key interventions, and overcoming barriers.
Rapid Advice: Treatment of Tuberculosis in Children (document)
This document provides recommendations based on recent evidence on the correct dosages of antituberculosis medicines for use in children and the regimens that should be used for different manifestations of the disease in children. Risks and benefits, acceptability, feasibility, cost and financial implications have all been considered.
Pediatric Infectious Disease Referral Guidelines: Tuberculosis in Children (document)
This guideline provides a simple outline for what action to take when a child presents with TB.
Guidelines for the Treatment of Tuberculosis (document)
The recommendations in this document are intended to guide the treatment of tuberculosis in settings where mycobacterial cultures, drug susceptibility testing, radiographic facilities, and second-line drugs are routinely available. New additions to guidelines include marking the responsibility for successful treatment clearly assigned to the public health program or private provider, not to the patient and that the initial treatment strategy use patient-centered case management with an adherence plan that emphasizes direct observation of therapy.
Guidelines for Targeted Tuberculosis Testing and Treatment of Latent Tuberculosis Infection (document)
CDC and American Thoracic Society releases new and updated recommendations for targeted tuberculin testing and treatment regimens for persons with latent tuberculosis infection (LTBI).
Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis (document)
These updated guidelines from CDC and its partners include recommendations for managing pharmacologic interactions that can result when patients receive antiretroviral drugs for treatment of human immunodeficiency virus (HIV) infection together with rifamycins for treatment of tuberculosis. New content calls for the use of newer antiretroviral drugs, including those in new classes, ie CCR5 receptor antagonists and integrase inhibitors. Additional recommendations are made in regard to utilizing rifampin with antiretroviral therapy.
Tuberculosis Care and Control in Refugee and Displaced Populations: An Interagency Field Manual (document)
This manual highlights the issues relating to the care of patients with tuberculosis (TB) and controlling the transmission of the disease in refugee and displaced populations. The new strategy outlined in six components includes: political commitment and sustained financing; case detection through quality-assured bacteriology; standardized short-course chemotherapy with supervision and patient support; an effective drug supply and management system; monitoring and evaluation system, and impact measurement.
Page 81 of 108 · Total posts: 0
←First 80 81 82 Last→